bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2018: J M A M F J
2017: D N O S A J J

 
  Other news for:
Family Planning
Breast Neoplasms
Colonic Neoplasms
Neoplasms
Ovarian Neoplasms
Uterine Neoplasms
 Resources from HONselect
The Pill Lowers Ovarian Cancer Risk, Even for Smokers

By E.J. Mundell

THURSDAY, Jan. 18, 2018 (HealthDay News) -- It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

According to the study from the U.S. National Cancer Institute, these trends were also observed for endometrial cancer as well.

Long-term use of the pill was linked to reductions in risk for both cancers, and this was "generally consistent across health behaviors," according to a team led by Kara Michels, a cancer institute epidemiologist.

The researchers looked at data from a U.S. study that tracked the health of women from 1995 to 2011. At least 100,000 of the women said they were using an oral contraceptive at the beginning of the study.

Michels' group found a 40 percent reduction in the risk of ovarian cancer for women who used the pill for 10 years or more. Furthermore, that benefit was similar for smokers and nonsmokers, and for slim and heavier women, the investigators noted.

As for endometrial cancers -- tumors of the uterine lining -- the benefit was even greater for women with less healthy lifestyle habits.

For example, women who smoked experienced a 53 percent drop in risk for endometrial cancer while on an oral contraceptive. And obese women who were on the pill saw an even greater benefit -- a 64 percent reduction in risk for endometrial cancers, the team reported.

However, long-term use of the pill appeared to have no effect on a woman's odds for either breast or colon cancers.

Just how might hormonal contraception shield women from ovarian and endometrial tumors? According to Michels' group, because the pill supplies its own dose of one hormone, progestin, long-term use might then trigger a reduction in a second hormone, estradiol, "across the menstrual cycle."

Exposure to such hormones has been linked to raised rates of certain cancers.

One cancer specialist who reviewed the findings said they expand on existing research.

"This study confirms that long-term use [of the pill] causes a profound reduction in the risk of ovarian and endometrial cancers," said Dr. Stephen Rubin, chief of gynecologic oncology at Fox Chase Cancer Center in Philadelphia.

Ovarian cancer is a "silent killer" because it is often detected only in its later stages. According to the American Cancer Society, more than 22,000 U.S. women will receive a diagnosis of the disease in 2018, and it will claim more than 14,000 lives.

Endometrial cancer is less lethal, but more common. According to the cancer society, more than 63,000 women will be diagnosed with such tumors this year, while about 11,000 will die from the disease.

The new study was published Jan. 18 in JAMA Oncology.

More information

Find out more about ovarian cancer at the American Cancer Society.

SOURCES: Stephen Rubin, M.D., professor and chief, division of gynecologic oncology, and Grotzinger-Raab Chair in Surgical Oncology, Fox Chase Cancer Center, Philadelphia; Jan. 18, 2018, JAMA Oncology

Copyright © 2018 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=730266

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Neoplasms
Women
Ovarian Neoplasms
Risk
Endometrial Neoplasms
Hormones
Breast
Research Personnel
Colonic Neoplasms
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact